Jazz Pharmaceuticals plc. (NASDAQ:JAZZ) Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ET
Company Participants
Andrea Flynn - Vice President and Head-Investor Relations
Bruce Cozadd - Chairman and Chief Executive Officer
Renée Galá - President and Chief Operating Officer
Rob Iannone - Executive Vice President and Global Head-R&D
Phil Johnson - Executive Vice President and Chief Financial Officer
Conference Call Participants
Jessica Fye - JPMorgan
Jason Gerberry - Bank of America
Marc Goodman - Leerink Partners
Ami Fadia - Needham
Anastasia Parafestas - Jefferies
David Amsellem - Piper Sandler
Andrea Newkirk - Goldman Sachs
Michael Riad - Morgan Stanley
Joon Lee - Truist
Gary Nachman - Raymond James
Operator
Ladies and gentlemen. Thank you for standing by. My name is Abbie, and I’ll be your operator today. At this time, I would like to welcome everyone to the Jazz Pharmaceuticals Third Quarter 2024 Earnings Call. All lines have been placed on mute to prevent any background. After the speakers’ remarks there will be a question-and-answer session. [Operator Instructions] Thank you.
I would now like to turn the conference over to Andrea Flynn, Vice President and Head of Investor Relations. You may begin.
Andrea Flynn
Thank you, operator, and good afternoon, everyone Today, Jazz Pharmaceuticals reported its third quarter 2024 financial results. The slide presentation accompanying this webcast is available on the Investors section of our website. Investors may also refer to the press release we issued earlier today, which is also posted to our website.
On the call today are Bruce Cozadd, Chairman and Chief Executive Officer; Renée Galá, President and Chief Operating Officer; Rob Iannone, Executive Vice President and Global Head of R&D; and Phil Johnson, Chief Financial Officer.
On Slide 2, I’d like to remind you that today’s webcast includes forward-looking statements, such as those related to our future financial and operating results, growth potential and anticipated development and commercialization milestones and goals, which involve risks and uncertainties that could cause actual events, performance and results to differ materially from those contained in these forward-looking statements. We encourage you to review the statements contained in today’s press release, in our slide deck and the risks and uncertainties described in our SEC filings, which identify certain factors that may cause the company’s actual events, performance and results to differ materially from those contained in the forward-looking statements made on today’s webcast. We undertake no duty or obligation to update our forward-looking statements.